Evidence map›Paper›PMID 41667809›Full record

ArticleCommunications biology2026

The core clock transcription factor TOC1 binds directly to defence gene promoters regulating immunity in Arabidopsis.

Shannon-Leigh Sparks, Laura C Roden, Robert A Ingle

Erratum issuedAbstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Shannon-Leigh SparksDepartment of Molecular and Cell Biology, University of Cape Town, Rondebosch, South Africa.ORCID http://orcid.org/0000-0002-3110-7084
Laura C RodenDepartment of Molecular and Cell Biology, University of Cape Town, Rondebosch, South Africa. ad3101@coventry.ac.uk.ORCID http://orcid.org/0000-0002-1941-898X
Robert A IngleDepartment of Molecular and Cell Biology, University of Cape Town, Rondebosch, South Africa. robert.ingle@uct.ac.za.ORCID http://orcid.org/0000-0002-8362-3777

Funding

National Research Foundation (NRF) 105819
6 · The paper itself

Abstract

The plant circadian clock drives temporal differences in susceptibility to pathogens. We investigated the role of TIMING OF CAB EXPRESSION 1 (TOC1) in the regulation of defence against Botrytis cinerea in Arabidopsis. The temporal variation in susceptibility to B. cinerea observed in wild-type Arabidopsis was abolished in TOC1-ox and toc1-2 plants under both diurnal and constant light conditions. In addition, TOC1-ox plants were more susceptible than Col-0 following inoculation at dawn, while inoculation at night led to enhanced resistance in toc1-2 plants versus C24 plants, suggesting that TOC1 is a negative regulator of immunity. RNA-seq analysis showed that the genes mis-regulated in toc1-2 plants had significant enrichment for terms related to biotic stress, an overrepresentation of G-box elements in their promoters and included genes encoding key transcription factors (TFs) involved in defence against necrotrophic pathogens. Chromatin immunoprecipitation-qPCR showed that TOC1 occupies G-box containing regions of the defence TFs ERF4, ORA47, ORA59 and WRKY33 in a pathogen-responsive and MYC2-dependent manner. We suggest that the phased TOC1 occupancy of defence gene promoters contributes to the gating of plant immunity against necrotrophic pathogens, while the MYC2-dependent release of TOC1 in response to pathogen detection allows plants to mount an acute immune response.

Indexed as

ArabidopsisArabidopsis ProteinsGene Expression Regulation, PlantPlant DiseasesPlant ImmunityPromoter Regions, GeneticTranscription FactorsBotrytisCircadian ClocksArabidopsis ProteinsTOC1 protein, ArabidopsisTranscription Factors

Identifiers

PMID41667809
PMCPMC13002877

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.